Akebia Therapeutics, Inc.

US$0.40As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AKBAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (25.36%)
Div yield —
ROE (143.83%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.23
PE TTM —
TSR TTM (81.84%)
Mkt cap US$111.4M
ROIC (5.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.471
17.39%
(86.62%)
Sell 0|4|7|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
13.83%
7.31%
5.67%
8.60%
Revenue$M
7.623
7.886
8.319
8.562
1.67%
4.36%
10.94%
15.20%
Peers (US$111.4M)
Cap (US$)
PE
126.2M
—
110.5M
—
111.5M
49.46x
Capital
TTM
5Y
10Y
Leveragex
0.427
0.120
0.130
EBIT/Intx
17.86
0.349
0.422
Own earn%
(1.59)
78.49
63.84
Sh yield%
35.90
26.33
23.28
Owners
Insiders/Inst%
0.22
60.20
Short interest%
3.16
SBC / revenue%
2.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
2–9
$1 testx
—
Incr. ROIC%
7